Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion.

Kurozumi, Kazuhiko; Fujii, Kentaro; Washio, Kana; Ishida, Joji; Otani, Yoshihiro; Sudo, Tamotsu; Tahara, Makoto; Ichimura, Koichi; Ennishi, Daisuke; Date, Isao

Kurozumi, Kazuhiko; Fujii, Kentaro; Washio, Kana; Ishida, Joji; Otani, Yoshihiro; Sudo, Tamotsu; Tahara, Makoto; Ichimura, Koichi; Ennishi, Daisuke; Date, Isao.

Afiliación

Kurozumi K; Department of Neurosurgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
Fujii K; Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Washio K; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
Ishida J; Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Otani Y; Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Sudo T; Section of Translational Research, Hyogo Cancer Center, Akashi, Japan.
Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Ichimura K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.
Ennishi D; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
Date I; Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Neurooncol Adv ; 4(1): vdac094, 2022.

Article en En | MEDLINE | ID: mdl-35821677

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google